I Feel Completely Healthy, Should I Still Get Tested for Groundwater Exposure?

Feeling healthy is a good thing. Nobody is suggesting otherwise. But feeling healthy and having no developing health issues are not the same thing, and for anyone with a history in northeast Wichita, that distinction is not a technicality. It is the entire reason the Clearway Testing program exists.

The chemicals found in the groundwater beneath the 29th and Grove area, trichloroethylene (TCE) and perchloroethylene (PCE), are volatile organic compounds linked to health conditions that are specifically, clinically, and medically known for producing no noticeable symptoms during their early and most treatable stages.

A person can feel completely normal, go to work every day, exercise, sleep well, and have no idea that something is developing in the background.

That is not a worst-case scenario designed to scare you. That is how these conditions work, documented in clinical research and confirmed by organizations including the National Kidney Foundation, the American Cancer Society, and the National Cancer Institute. This article explains exactly why healthy-feeling people with a connection to this area should get tested, what the science says about silent disease progression, and what early detection actually changes.

Quick Facts:

• Free health testing through Clearway Testing is available through December 31, 2026
• No insurance is required
• Testing is designed specifically to catch conditions that produce no early symptoms
• Early detection of the cancers linked to TCE and PCE dramatically improves treatment outcomes
• Health professionals recommend getting tested annually through the end of the program
• Testing is available at multiple Wichita-area clinics and at home for homebound residents

“I Feel Fine” Is Not a Health Clearance

The health effects most strongly associated with long-term TCE and PCE exposure are kidney cancer, liver cancer, and non-Hodgkin lymphoma. Each of these conditions shares a critical characteristic. They are largely asymptomatic in their early stages.

Kidney cancer, which carries the strongest and most consistently documented link to TCE exposure in the scientific literature, is particularly known for this. According to the National Kidney Foundation, kidney cancer does not always cause symptoms in the early stages, and many people are diagnosed only when the cancer is found accidentally during imaging ordered for an entirely different reason. Roughly half of all people with kidney cancer have no signs or symptoms at the time of diagnosis. They were not in pain. They were not losing weight. There was nothing telling them to go to the doctor.

Liver cancer follows the same pattern. Elevated liver enzymes, which a standard blood panel can detect, often appear before any physical symptom does. By the time symptoms like abdominal discomfort, jaundice, or unexplained fatigue appear, the disease has typically progressed beyond its earliest stage. Non-Hodgkin lymphoma can produce mild fatigue or occasional swollen glands that most people attribute to ordinary tiredness or minor illness, not to a condition that has been quietly developing for years.

This is not unique to TCE and PCE exposure. It is how these organ-related conditions behave regardless of their cause. The human body compensates remarkably well. The kidneys can lose significant function before a person feels any different. The liver has enormous regenerative capacity and can mask early damage for an extended period. A person can feel completely fine while lab values that only a blood sample and urinalysis would reveal are already signaling that something needs attention.

The 29th and Grove groundwater contamination involves VOC compounds that leach through soil and migrate through the aquifer over long distances, reaching concentrations in groundwater that have remained above U.S. EPA drinking water standards in portions of the affected area for years. People in the contamination zone were exposed through multiple pathways, including well water for those with private wells, indoor air through vapor intrusion, and general environmental contact. The monitoring data and groundwater samples collected across the plume document a contamination situation with real health implications for the community. Feeling well during the years of exposure, and feeling well today, does not mean the exposure had no effect. It may mean the effect is still developing, still below the threshold of symptoms, still at a stage where detection and intervention are most effective.

The Latency Window Explains Why Timing Matters Right Now

The documented latency period between TCE exposure and the development of related cancers ranges from 18 to 34 years. This is peer-reviewed, published science from occupational and environmental health research. What that means for people who lived or worked in northeast Wichita is specific and worth thinking through directly.

Someone who grew up in the Millair neighborhood in the 1980s is now in their forties or fifties. Someone who worked in a business in the contamination zone throughout the 1990s is past the 25-year mark. Someone who rented in the area between 2000 and 2010 is now squarely inside the window. These are not abstract risk factors. They are real people in a real timeframe where the science says related health effects are most statistically likely to emerge.

A KDHE health study finalized in April 2023 found elevated rates of liver cancer in the 29th and Grove study area. These are not statistics about people who felt sick. They are statistics about a community where documented pollutants were present in the groundwater and soil for decades while life went on normally for the people living there. Feeling well during those years was the norm. It does not mean the exposure carried no consequence.

What Early Detection Actually Changes

This is where the conversation becomes concrete and the case for testing becomes undeniable.

When kidney cancer is detected at Stage I, meaning the tumor is small and confined to the kidney with no spread to other organs or tissue, the five-year survival rate is above 90 percent. Treatment at this stage typically involves surgery to remove the tumor, and outcomes are favorable. When kidney cancer is detected at Stage IV, meaning the cancer has spread to distant organs including the lungs, bones, or liver, the five-year survival rate drops to approximately 18 percent.

That gap between above 90% and 18% is what early detection does.

It is not academic. It is the difference between a manageable diagnosis caught through a routine blood sample and a deeply difficult one discovered after symptoms finally appear. The only way to find kidney cancer at Stage I in a person who feels completely healthy is through the kind of targeted screening that the Clearway Testing program provides. The same logic applies to elevated liver enzymes that signal the beginning of liver stress and to early immune system irregularities visible on a complete blood count long before any symptom emerges.

Free testing through Clearway partners is designed around exactly this reality. The screenings are not looking for conditions you already know about. They are looking for what your body cannot tell you on its own.

What the Free Testing Screens For

Testing through Clearway partner clinics evaluates the organ systems most associated with TCE and PCE exposure. These tests do not look for VOC compounds directly in your body. They assess kidney function, liver function, blood health, and overall organ status using standard laboratory analysis, giving you and your physician a clear picture of where things stand.

Clearway Testing screenings include:

Test	What It Can Catch Before Symptoms Appear
Comprehensive metabolic panel	Elevated liver enzymes, abnormal kidney function markers, blood glucose and electrolyte imbalances
Complete blood count	Anemia, abnormal white blood cell counts, early immune system flags
Urinalysis	Blood in urine, protein in urine, early kidney stress indicators
Alpha-fetoprotein (AFP) test	Elevated AFP levels associated with early liver conditions, at select locations
Abdominal ultrasound	Structural abnormalities in liver and kidneys, at select locations for qualifying patients
Basic medical checkup	General health assessment including blood pressure and physical examination

Every one of these tests is capable of surfacing something important in a person who feels completely healthy, because that is specifically what they are designed to do. They evaluate what your body cannot communicate on its own through symptoms, drawing on laboratory analysis, clinical guidance from U.S. health agencies, and the expertise of the medical professionals at each Clearway partner clinic.

After your appointment, a nurse or health professional from the Clearway partner clinic where you were tested will call you personally to explain your results in plain language, walk through what they mean, and identify any next steps. If results indicate something that needs follow-up care, you are connected to trusted local providers. If everything looks good, you have a documented health baseline backed by real lab work rather than assumption.

Health professionals recommend returning for testing annually through the end of the program. A single screening gives you a baseline. Annual testing tracks how your kidney function, liver function, and blood health change over time, which is how physicians catch slow-developing conditions at their earliest and most treatable point. One appointment is a snapshot. Yearly testing builds a health record that works in your favor.

The Cost of Waiting for a Symptom That May Not Come

There is a quiet logic many people apply when they feel well. They tell themselves they will get tested when something bothers them, when they have more time, or when the deadline gets closer.

The clinical problem with that reasoning, in this specific situation, is that the conditions linked to TCE and PCE exposure are not conditions that reliably warn you before they have advanced.

Waiting for a symptom to appear before seeking medical guidance is, in the case of early-stage kidney or liver cancer, waiting for a sign that may not arrive until the disease has already moved well beyond where it started. The monitoring wells, soil samples, and groundwater analysis conducted by KDHE and Union Pacific across the contamination zone document a contamination situation that has been affecting this community for decades. The public health resources and funding now available through Clearway Testing exist because there is a real and documented basis for concern. That basis is strongest precisely for people who feel fine today and have a history in the area.

Free testing through Clearway Testing partners is available through December 31, 2026. That window is defined. It was funded through $3.5 million in state, local, and philanthropic grants specifically to reach people with a connection to this contamination during a period when early detection can still make the most meaningful difference. Waiting until you feel sick is not a strategy. It is the opposite of what this program was built to prevent.

How to Schedule Free Testing Through Clearway

Testing is available at multiple partner clinics across Wichita and Sedgwick County. No insurance is needed. No documentation of your past address or exposure history is required. You contact a partner, schedule an appointment, get screened by experienced medical professionals at a trusted community clinic, and a nurse or health professional from that clinic calls you with your results.

Clearway Testing Partner Clinics:

• GraceMed Health Clinic | 316-866-2000 | gracemed.org
• HealthCore Clinic | 316-691-0249 | healthcoreclinic.org
• Hunter Health | 316-262-2415 | hunterhealth.org
• Love Clinic and Med Spa | 316-669-4770 | loveclinicmedspa.com
• Wichita Black Nurses Association | 316-249-1926 | wichitabna.org

If you are homebound and cannot travel to a clinic, contact the Wichita Black Nurses Association at 316-882-1778 to inquire about a free at-home visit.

Feeling Fine Is the Best Time to Get Tested

Feeling healthy is not a reason to skip testing. It is the best possible position to be in when you go.

When lab results come back normal in a healthy-feeling person, the result is real information, a documented baseline backed by actual clinical analysis confirming that things look good. And if anything comes back that needs attention, you are catching it at the point in time when your options for care are widest, your treatment outcomes are best, and the conditions linked to your exposure history are most manageable.

Come back every year. The program from Clearway currently runs through December 31, 2026, and each annual visit adds another data point to your health record. That record is what gives you and your physician the clearest possible picture of how your health is tracking over time. That is what this testing program is for. Not for people who are already sick. For people who feel fine and want to stay that way.

Free testing is available through December 31, 2026. No insurance required.